NRX Pharmaceuticals Inc.(NRXP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NRXP NRX Pharmaceuticals Inc.

Market Closed 04-24 16:00:00 EDT

2.94

+0.10

+3.52%

盘后2.97

+0.03+1.02%

19:57 EDT

High3.01	Low2.86	Vol473.45K
Open2.88	D1 Closing2.84	Amplitude5.28%
Mkt Cap97.22M	Tradable Cap71.38M	Total Shares33.07M
T/O1.39M	T/O Rate1.95%	Tradable Shares24.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":2.94,"timestamp":1777060800000,"preClose":2.84,"halted":0,"volume":473447,"hourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.94,"latestTime":"19:57 EDT","volume":2311,"amount":6859.075,"timestamp":1777075075445,"change":0.03,"changeRate":0.010204,"amplitude":0.02534},"delay":0,"changeRate":0.03521126760563384,"floatShares":24277600,"shares":33067630,"eps":-1.339999,"marketStatus":"Market Closed","change":0.1,"latestTime":"04-24 16:00:00 EDT","open":2.88,"high":3.01,"low":2.86,"amount":1390316.7903586,"amplitude":0.052817,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.339999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.84,"preHourTrading":{"tag":"盘前","latestPrice":2.89,"preClose":2.84,"latestTime":"09:27 EDT","volume":2833,"amount":8209.5968681,"timestamp":1777037270031,"change":0.05,"changeRate":0.017606,"amplitude":0.052817},"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.94,"latestTime":"19:57 EDT","volume":2311,"amount":6859.075,"timestamp":1777075075445,"change":0.03,"changeRate":0.010204,"amplitude":0.02534},"volumeRatio":0.23148680082083017,"impliedVol":0.7688,"impliedVolPercentile":0.1793},"requestUrl":"/m/hq/s/NRXP","defaultTab":"news","newsList":[{"id":"2629839359","title":"NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2629839359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629839359?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:58","pubTimestamp":1776945480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 23, 2026 07:58 ET (11:58 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629801046","title":"NRX Pharmaceuticals Inc - Receives Positive FDA Discipline Review Letter Requesting Only Minor Administrative Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2629801046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629801046?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUAWRN7R:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629801019","title":"NRX Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2629801019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629801019?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUAWRN7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629101420","title":"NRX Pharmaceuticals Inc - FDA Office of Generic Drugs Voices Support for NRX Anda Approval in Current Review Cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=2629101420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629101420?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUAWRN7R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010467","title":"NRX Pharmaceuticals Inc - in the Process of of Submitting Nda to Align Ketamine Labeling With Depression and Suicidality Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010467?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUAWRN7R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628729056","title":"White House shift on psychedelics positive for NRx, says D. Boral","url":"https://stock-news.laohu8.com/highlight/detail?id=2628729056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628729056?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:07","pubTimestamp":1776694074,"startTime":"0","endTime":"0","summary":"D. Boral Capital analyst Jason Kolbert says NRx Pharmaceuticals (NRXP) is advancing a ketamine-based therapeutic strategy at a time when U.S. polic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/white-house-shift-on-psychedelics-positive-for-nrx-says-d-boral-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/white-house-shift-on-psychedelics-positive-for-nrx-says-d-boral-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628955725","title":"NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2628955725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628955725?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:08","pubTimestamp":1776690480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 20, 2026 09:08 ET (13:08 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628429897","title":"NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality","url":"https://stock-news.laohu8.com/highlight/detail?id=2628429897","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628429897?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682800,"startTime":"0","endTime":"0","summary":"to facilitate the timely evaluation and approval of drugs that meet standards for approval under section 505 of the Federal Food, Drug, and Cosmetic Act. This aspect of the executive order is expected to facilitate NRx’s proposed use of Real World Evidence and already-completed federally-funded clinical trials in support of drug approval. The order is consistent with recently-announced guidance from an FDA Type C m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276858/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Welcomes-Presidential-Initiative-to-Accelerate-Approval-of-Psychedelic-Medications-to-Treat-Depression-PTSD-and-Suicidality.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP","AAQC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627978212","title":"NRx Pharmaceuticals announces incorporation of NRx Defense Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2627978212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627978212?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:26","pubTimestamp":1776353194,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced the incorporation of NRx Defense Systems, a Florida-based research and development subsidiary, charged with de...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-announces-incorporation-of-nrx-defense-systems-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-announces-incorporation-of-nrx-defense-systems-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627466231","title":"BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2627466231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627466231?lang=en_us&edition=fundamental","pubTime":"2026-04-16 01:35","pubTimestamp":1776274543,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI SystemsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL6N40Y0QD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOD","KMX","FNB","OSIS","WULF","SNVD.UK","AVGW","AVGO","NKE","RVMD","NVDD","SYRE","ABUS","LLY","PNC","STNE","WINA","BIRD","PDSB","ALLO","QUBT","NVDW","LLYX","EGBN","NEM","NVDY","NVDL","BAC","NVDA","TEM","ASBP","NXL","SPRY","AEO","TE","FHN","GLOO","NOV","DTIL","TNGX","BORR","UNP","NRXP","ANV","CSX","IONQ","RGTI","GTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627286290","title":"BUZZ-NRx Pharmaceuticals rises as it launches defense-focused mental health unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2627286290","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627286290?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:16","pubTimestamp":1776251772,"startTime":"0","endTime":"0","summary":"BUZZ-NRx Pharmaceuticals rises as it launches defense-focused mental health unit** Shares of biotech firm NRx Pharmaceuticals NRXP.O rise about 2% to $2.55 premarket** Co says it launched NRx Defense Systems to develop treatments for depression and PTSD, a stress disorder linked to traumatic events, for military and first responders** Says the unit will combine its experimental drug NRX-101 with non-invasive brain stimulation using magnetic pulses** Says the aim is portable, AI-enabled devices that can be used in the field without specialist medical staff** Says the unit will be led by former Pentagon executive Dennis McBride and is partnering Zeta Surgical on brain-guided technology** Co says it plans to show a prototype at a medical conference in June** As of last close, stock down ~8% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4N40Y0XG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627828630","title":"NRx advances robotic TMS plus D-cycloserine neuroplastic therapy for military, responders","url":"https://stock-news.laohu8.com/highlight/detail?id=2627828630","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627828630?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:02","pubTimestamp":1776250967,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals formed NRx Defense Systems to develop combined neuroplastic therapy pairing D-cycloserine  with robotic-enabled transcranial magnetic stimulation for depression and PTSD in military and first-responder settings.Program targets forward-deployable, AI-enabled treatment delivery designed to reduce reliance on specialized medical staff, addressing force-readiness constraints tied to antidepressant use.Prototype development will run with Zeta Surgical, using its FDA 510-cleared AI neuronavigation platform for TMS navigation cleared in October 2025.NRx expects to unveil prototype system at Clinical TMS Society annual meeting in Boston from June 4-6, 2026.NRx Defense Systems leadership includes President Dennis McBride, supported by Chief Medical Innovation Officer Joshua Brown, with Chairman Jonathan Javitt overseeing subsidiary.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL3DS8P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","NDAQ","LU2210150020.SGD","SG9999014039.USD","IE00B64PRP62.GBP","BK4007","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU0314104364.USD","NRXP","BK4112","IE00BN0W2T93.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627728633","title":"NRX Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined With Neuroplastic Therapy for Military and First Responder Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2627728633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627728633?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:01","pubTimestamp":1776250868,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y06S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627028638","title":"NRX Pharmaceuticals Inc: Development Initiative to Be Conducted Through R&D Unit NRX Defense Systems, in Partnership With Zeta Surgical","url":"https://stock-news.laohu8.com/highlight/detail?id=2627028638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627028638?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:01","pubTimestamp":1776250868,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y06S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432937","title":"NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Appointment of Glenn Tyson as the Company’s First Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432937?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA6FD3YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432620","title":"Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432620","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432620?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078000,"startTime":"0","endTime":"0","summary":"-- Mr Tyson has both clinical experience treating patients with serious. mental health disorders and 25 years of successful industry commercial. experience in the development and sales of medications in this field. -- Mr. Tyson is appointed as NRx anticipates approval of an ANDA for. preservative-free ketamine and near term submission of a New Drug. As CCO, Mr. Tyson will be responsible for building world-class market-access, distribution, sales and marketing functions to support commercialization of this NDA, as well as future pipeline assets in psychiatry designed to address the tremendous unmet needs of people suffering with seri","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","BK4212","LU1571399168.USD","BK4007","TSN","BK4232","BK4504","R","BK4533","NRXP","BK4022","LU1699723380.USD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625167634","title":"NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2625167634","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625167634?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473200,"startTime":"0","endTime":"0","summary":"NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx’s preservative-free ketamine product. Labeling remains subject to final supervisory ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268338/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-FDA-Labeling-Alignment-for-NRx-s-Preservative-Free-Ketamine-Application.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4007","NRXP","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623140311","title":"NRx unit Hope Therapeutics partners with Emobot to deploy AI depression monitoring networkwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2623140311","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623140311?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:07","pubTimestamp":1774868867,"startTime":"0","endTime":"0","summary":"Hope Therapeutics, NRx Pharmaceuticals subsidiary, formed strategic partnership with Emobot to deploy AI “Depression Thermometer” across its interventional psychiatry clinic network.Rollout targets relapse detection in treatment-resistant depression, where about 50% of patients relapse within 6–12 months between visits.Emobot platform validation across three prospective studies showed concordance with MADRS  and PHQ-9 .Hope expects integration to support earlier “recapture” interventions such as maintenance ketamine or TMS sessions, aiming to double patient success rates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL89G8n0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4585","LU2210149790.SGD","IE00BN0W2W23.USD","NRXP","LU2095319765.USD","SG9999014005.SGD","BK4007","BK4112","LU2210150020.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4588","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311325","title":"Hope Therapeutics, an NRX Pharmaceuticals Subsidiary (Nasdaq:Nrxp), Announces Strategic Partnership With Emobot to Integrate Its AI-Powered “Depression Thermometer” Across Its Interventional Psychiatry Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311325","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311325?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:00","pubTimestamp":1774868403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA5XLGLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622022585","title":"Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022585","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622022585?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:11","pubTimestamp":1774433472,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NRX Pharmaceuticals (NRXP), Rezolute (RZLT) and Spec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-nrx-pharmaceuticals-nrxp-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-nrx-pharmaceuticals-nrxp-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","RZLT","BK4139","LU0029874061.USD","BLSG","BK4007","BK4581","LU0128526141.USD","BK4588","BK4112","NRXP","BK4137","XBI","BLSX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.salbergco.com","stockEarnings":[{"period":"1week","weight":0.1529},{"period":"1month","weight":0.2199},{"period":"3month","weight":0.3548},{"period":"6month","weight":-0.0667},{"period":"1year","weight":0.4203},{"period":"ytd","weight":0.0849}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.074525},{"month":2,"riseRate":0.2,"avgChangeRate":-0.102766},{"month":3,"riseRate":0.4,"avgChangeRate":-0.034339},{"month":4,"riseRate":0.4,"avgChangeRate":-0.104061},{"month":5,"riseRate":0.75,"avgChangeRate":0.071255},{"month":6,"riseRate":0.4,"avgChangeRate":-0.166652},{"month":7,"riseRate":0.4,"avgChangeRate":0.039708},{"month":8,"riseRate":0.2,"avgChangeRate":-0.14211},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012776},{"month":10,"riseRate":0.6,"avgChangeRate":0.037482},{"month":11,"riseRate":0.4,"avgChangeRate":0.048439},{"month":12,"riseRate":0.6,"avgChangeRate":0.121824}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NRX Pharmaceuticals Inc.(NRXP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NRX Pharmaceuticals Inc.(NRXP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}